Aditi Shastri, MD: Clinicians Need to ‘Come Together’ on TP53-Mutated MDS
The HemOnc Pulse
Upcoming Drugs and Research in MDS
Discussion on the latest drugs and research in the field of MDS, including telomerase inhibitor IMETEL stat, immune immunotherapy drug sabatolimab, XPO1 inhibitors, Venetoclax, and BCL2 inhibition.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
